i-spero® is a new personalised medicine approach to improve the treatment of depression within primary care.
Sufferers with low mood anxiety and depression who present in primary care are given access to i-spero® to complete a simple online test (P1vital® PReDicT Test — CE marked medical device) and objective questionnaires.
i-spero® monitors progress against a personal treatment plan and sends reminders when actions and periodic outcome assessments are due.
i-spero® reviews outcomes against a personal treatment plan and alerts the user to take action when needed. The clinician also monitors i-spero® and can contact the patient in order to discuss recommended changes to their treatment plan.
i-spero® monitors outcome assessments on an ongoing basis through to recovery and records and monitors any changes for use in their medical record.
If you are a primary care provider, or are responsible for the purchasing/commissioning of primary care or specialist mental health services we would welcome a discussion.